Skip Navigation LinksHome > November 2012 - Volume 21 - Issue 6 > Favourable prognostic factors of subsequent screen-detected...
Text sizing:
A
A
A
European Journal of Cancer Prevention:
doi: 10.1097/CEJ.0b013e328350b0f4
Review Article: Breast Cancer

Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50–69

Chiarelli, Anna M.a,b; Edwards, Sarah A.a,b; Sheppard, Amanda J.c; Mirea, Luciad; Chong, Nelsone; Paszat, Lawrencee,f; Shumak, Rene S.a; O'Malley, Frances P.g; the Breast Screening Study Group

Collapse Box

Abstract

Most studies reporting more favourable biological features of screen-detected breast cancers compared with symptomatic or interval cancers include initial or prevalent screens and therefore may not indicate the real benefit of screening on breast cancer mortality. We conducted case–case comparisons within a cohort of eligible women (N=771 715) who were aged 50–69 between 1 January 1995 and 31 December 2003. A randomly selected sample of breast cancers (N=1848) diagnosed among these women were compared by detection method. Tumour characteristics of interval cancers (N=362) diagnosed after 6–24 months of a negative screen or symptomatic breast cancers (N=491) were compared with subsequent screen-detected breast cancers diagnosed within 6 months of a positive screen (N=995) using polytomous logistic regression. Tumours were evaluated for clinical presentation, histology and expression of hormone receptors. Women with symptomatic detected [odds ratio (OR)=7.48, 95% confidence interval (CI)=5.38–10.38] and interval cancers (OR=2.20, 95% CI=1.56–3.10) were more often diagnosed at stage III–IV versus I than women with rescreen-detected cancers. After adjusting for tumour size, women with symptomatic cancers had tumours of higher grade (OR=1.50, 95% CI=1.05–2.15) and mitotic score (OR=1.69, 95% CI=1.15–2.49) and women with interval cancers had tumours of higher mitotic score (OR=1.52, 95% CI=1.01–2.28) compared with women diagnosed at screening. Subsequent screen-detected cancers are not only detected at an earlier stage but are also less aggressive, leading to a better prognosis. As long-term mortality reduction for breast screening may depend on subsequent screens, our study indicates that mammography screening can be effective in women aged 50–69.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.